ABSA GROUP LIMITED
Incorporated in the Republic of South Africa
Registration number: 1986/003934/06
ISIN: ZAE000255915
JSE share code: ABG
JSE bond issuer code: ABGI
('Absa Group' or 'the Group')
VOLUNTARY TRADING UPDATE AND TRADING STATEMENT FOR THE YEAR ENDED
31 DECEMBER 2022
Further to Absa Group's trading update and operational outlook of 7 December 2022, there is
greater certainty regarding our financial results for the year ended 31 December 2022. The
commentary below refers to the percentage change year-on-year in our normalised financial
results, which adjust for the consequences of separating from Barclays PLC.
We previously highlighted Ghana's sovereign debt crisis as a potential risk to our 2022
performance. With greater certainty on the terms of the proposed debt exchange programme
with the Ghana sovereign, we expect our credit impairments to increase significantly year-on-
year, mainly due to impairments on sovereign investment securities and related exposures in the
banking book.
Notwithstanding building significant coverage against our sovereign bond exposure in Ghana, the
rest of the Group performed strongly, such that our 2022 results are expected to be largely
consistent with our guidance on 7 December 2022.
Group revenue for 2022 is expected to increase by mid-teens year-on-year, driven by very strong
non-interest income growth in part due to a recovery in life insurance revenue off a low base.
Given high single digit operating expense growth, we expect substantial pre-provision profit
growth in the mid-20s. Consequently, our 2022 cost-to-income ratio is expected to improve
noticeably to the low 50s, in line with the first half 2022 ratio.
Our 2022 credit loss ratio is expected to be similar to our first half 2022 charge of 91 basis points
when excluding Ghana sovereign-related charges.
Our return on equity is expected to improve year-on-year to slightly below 17%, well above our
cost of equity. Excluding impairment charges on Ghana sovereign-related exposures, our return
on equity is expected to be around 18%.
We expect all subsidiary entities to report capital levels in excess of local regulatory requirements.
Given our strong Group common equity tier 1 capital ratio, we expect to increase our dividend
payout ratio to at least 50% for the year.
Absa Group's IFRS headline earnings per share (HEPS) for 2022 is expected to increase by 10%
to 15% from the 2021 comparative of 2147.1 cents, to between 2362 and 2469 cents. IFRS
earnings per share for 2022 is expected to rise by 12% to 18%, to between 2396 and 2525 cents,
from 2139.6 cents in 2021. Normalised HEPS for 2022 is expected to increase by 10% to 15%,
to between 2417 and 2527 cents, from 2197 cents in 2021. Excluding the impairment charges
on Ghana sovereign-related exposures, our normalised HEPS for 2022 is expected to increase
by more than 20%.
Shareholders are advised that the financial information contained in this trading update and
trading statement has not been reviewed or reported on by our auditors.
We will release our 2022 financial results on 13 March 2023.
Johannesburg
17 February 2023
Enquiries:
Alan Hartdegen
E-mail: alan.hartdegen@absa.africa
Lead Independent Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited
Joint Sponsor:
Absa Bank Limited (Corporate & Investment Bank)
Editor's Note:
Normalised reporting
Given the process of separating from Barclays PLC, Absa Group continues to report IFRS-
compliant financial results and a normalised view. The latter adjusts for the consequences of the
separation and better reflects its underlying performance.
Date: 17-02-2023 08:55:00
Supplied by www.sharenet.co.za
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.